Aisling Capital Email Format
Venture Capital and Private Equity PrincipalsNew York, United States11-50 Employees
Aisling Capital is a New York-based investment firm focused on healthcare, operating in the venture capital and private equity space. The firm sees biotechnology-derived therapeutics, informed by genomic insights, as drivers of a forthcoming shift in how diseases are diagnosed, prevented, and treated. Its objective is to support leading global healthcare companies as they work to develop and commercialize new therapeutic products. Based in New York City, the firm maintains a relatively small team and concentrates its activity in the life sciences sector. It positions itself within the healthcare investment landscape as a specialist backing companies pursuing breakthroughs that could translate into new healthcare products.